Sleep Number Corporation (SNBR) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents mixed signals: while financial performance aligns with guidance, inventory issues and margin declines are concerning. Positive elements include cost savings and promising new product launches. However, the rapid product development poses execution risks, and management's unclear responses on cash flow timelines add uncertainty. Without a market cap, the stock's reaction is unpredictable, but given these factors, a neutral sentiment is appropriate.
Key Financial Performance
Full year net sales $1.41 billion, in line with guidance despite reduced marketing spend and lower traffic throughout the year.
Adjusted EBITDA $78 million, exceeding guidance of $70 million due to cost savings and operational efficiencies.
Use of cash for 2025 $18 million compared to the $50 million guidance, reflecting better cash management.
Pro forma adjusted EBITDA margin Approximately 9%, supported by cost savings and product line redesign.
Annualized cost reductions $185 million achieved, with an additional $50 million identified for 2026.
Q4 net sales $347 million, 8% below the same period in the prior year, impacted by a 53rd week in the prior year and store closures.
Q4 gross profit margin 55.6%, a 430 basis point decline due to a $9.6 million inventory obsolescence charge and higher tariffs.
Adjusted gross profit margin (excluding inventory charge) 58.4%.
Operating expenses in Q4 $197 million, down 9% year-over-year due to cost savings initiatives.
Adjusted EBITDA in Q4 $19 million, down $7 million versus the same period last year.
Full year gross margin 59%, down 60 basis points year-over-year, aligned with guidance when excluding inventory charge.
Full year operating expenses $824 million, a $136 million reduction from the prior year due to cost savings.
Full year free cash flow A use of $18 million, $30 million favorable to expectations but $21 million unfavorable compared to the prior year.
Capital expenditures $14 million, down $9 million compared to the prior year.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Launch: Launched ComfortMode mattress priced under $1,600, targeting a new customer segment. Sales exceeded expectations by 3.5x. Introduced additional models like ComfortMode Lux and ComfortNext line with advanced features. Climate Collection continues to offer premium features like active temperature management.
Market Positioning: Brand consideration among premium shoppers grew 10%, achieving the highest consideration in the premium category. New marketing strategies, including a partnership with Travis Kelce, are enhancing brand visibility.
Cost Reductions: Achieved $185 million in annualized cost reductions in 2025, with an additional $50 million planned for 2026. Adjusted EBITDA margin improved to 9%.
Marketing Efficiency: Modernized marketing strategies led to improved cost per acquisition and better funnel metrics. New creative campaigns and commercials are outperforming previous benchmarks.
Turnaround Strategy: Focused on streamlining operations, reducing fixed costs, and launching new products to drive growth. Engaged Guggenheim Securities to address liquidity and refinance credit facilities.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Liquidity and Capital Structure: The company is facing significant liquidity pressures due to industry-wide softness, inventory clearance for new product launches, and reduced marketing spend. They have engaged Guggenheim Securities to evaluate refinancing options and address credit facility challenges.
Macroeconomic and Weather Impacts: Severe weather and macroeconomic conditions in January and early February 2026 led to 236 store closures and significantly reduced sales at the start of the year.
Cost Structure and Turnaround Challenges: Despite achieving $185 million in cost reductions and planning for an additional $50 million in 2026, the company remains in turnaround mode and faces hurdles in achieving sustainable profitability.
Marketing and Sales Performance: While marketing changes have shown improvements, the company is still in the process of modernizing its marketing engine and faces challenges in converting brand strength into consistent sales growth.
Inventory and Product Launch Risks: The rapid development and launch of a new product line in just 10 months, which typically takes over 2 years, poses risks related to execution and inventory obsolescence. A $9.6 million inventory obsolescence charge was incurred in Q4 2025.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Expectations: Q1 net sales are expected to decline in the high teens due to softness at the beginning of the year. However, significant improvement in year-over-year revenue performance is expected in Q2, with double-digit sales growth anticipated in the second half of the year.
Adjusted EBITDA: Adjusted EBITDA for the full year is expected to increase in the high teens to mid-20s percent range year-over-year.
Free Cash Flow: Free cash flow is expected to be positive for the full year.
Product Launch Impact: The launch of new products, including the ComfortMode mattress and additional product lines, is expected to drive revenue growth and improve gross margins. The full impact of the new product launch is anticipated in Q2.
Marketing Strategy: Increased media spend and new creative assets, including a partnership with Travis Kelce, are expected to enhance marketing reach and drive sales growth in the second half of the year.
Cost Savings: An additional $50 million in annualized fixed cost reductions is planned for 2026, building on the $185 million already achieved.
Liquidity and Capital Structure: The company is actively addressing liquidity pressures and has engaged Guggenheim Securities to evaluate refinancing opportunities and improve financial flexibility.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What were the main pain points addressed with the new product launches, and how will the new beds impact ASPs, cost per bed, and margins?
A:The main pain points addressed were expanding the audience to include younger demographics and providing access to premium Sleep Number beds. The focus was on comfort, value, and durability. The new beds use luxurious materials and innovations like temperature management and micro coils, offering a premium experience at a more accessible price point. The ComfortMode bed has a strong margin profile, similar to the Climate360 beds, ensuring consistent margins across the product line. Gross margin for the ComfortMode bed improved by 10 percentage points compared to the previous C Series beds.
Q:What are the major sources of the $50 million additional savings expected this year, and will there be further clearance activity?
A:The $50 million savings come from logistics, delivery, last-mile labor model resets, and corporate overhead structure adjustments. All savings have been identified and are being executed, focusing on fixed costs. Clearance activity is expected as part of the product transition.
Q:What is the phasing plan for the rollout of the six new beds, and when will the store floors be fully set?
A:The ComfortMode bed and base were launched in January. Four new beds and a new base will be available for purchase starting March 23. Floors will begin being set on March 23, with most stores completed by mid-April and a few extending into May. The goal is to have floors ready by Memorial Day.
Q:Will the EBITDA growth referenced be based on the reported or pro forma number, and will it translate into positive free cash flow?
A:The EBITDA growth is based on the reported $78 million adjusted EBITDA base, with a high teens to mid-20s percent range improvement. If achieved, it will translate into positive free cash flow for the year.
Q:How is marketing spend expected to change in 2026 compared to 2025?
A:Marketing spend in 2026 will remain flat compared to 2025 but will be evenly distributed throughout the year. Q1 spend will decrease, while Q2, Q3, and Q4 will see increased spending to support the product rollout.
Q:Was the clearance of existing products expected, and will it impact margins in the first half of the year?
A:Yes, the clearance of existing products was expected as part of the product launch. There will be margin pressure in Q1 due to discounting and inventory clearance. However, the new ComfortMode bed is performing well, outselling its predecessors by 2x and exceeding sales plans by 3.5x.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer regarding the specific timeline for achieving positive free cash flow and the exact impact of marketing spend adjustments on demand generation.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Brand consideration
Brid design
CEO OKeefe
CFO search
Climate Collection
Climate minute
ClimateCool Climate
Collection ClimateCool
ComfortMode Lux
ComfortMode bed
ComfortMode entry
ComfortMode mattress
ComfortMode spot
ComfortNext line
comfort temperature
consideration premium
core
durability
experience
fact
inch
launch
line marketing
liquidity capital
marketing change
night
premium category
pressure industry
product line
structure turnaround
success
temperature material
SNBR Transcript
Sleep Number Corporation (SNBR) Q1 2026 Earnings Call Transcript
Unknown5-12
The company reported a significant decline in net sales and gross profit margin, driven by soft demand and reduced media investment. Despite new product launches and cost savings, management's guidance for Q2 remains cautious, with sales expected to be flat or slightly down. Concerns about liquidity and unclear communication on financial health further contribute to a negative sentiment. The lack of positive catalysts and the potential for continued financial pressure suggest a negative stock price movement over the next two weeks.
Sleep Number Corporation (SNBR) Q4 2025 Earnings Call Transcript
Unknown3-12
The earnings call presents mixed signals: while financial performance aligns with guidance, inventory issues and margin declines are concerning. Positive elements include cost savings and promising new product launches. However, the rapid product development poses execution risks, and management's unclear responses on cash flow timelines add uncertainty. Without a market cap, the stock's reaction is unpredictable, but given these factors, a neutral sentiment is appropriate.
Sleep Number Corporation (SNBR) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call revealed a 14% decline in revenue expectations and a lack of clear guidance for 2026 cash restructuring. Despite cost-saving measures and improved conversion rates, reduced media spend and uncertain product launch timing cast doubt on future performance. The Q&A session highlighted concerns about strategic changes, debt structure, and limited guidance, leading to a negative sentiment. Without market cap data, the prediction is a negative stock movement of -2% to -8% over the next two weeks.
Sleep Number Corporation (SNBR) Q2 2025 Earnings Call Transcript
Unknown7-30
The earnings call summary presents a mixed picture. Financial performance shows a decline in net sales, but cost-saving initiatives are positive. Product development efforts and market strategy are underway, though with some risks. The Q&A reveals management's reluctance to provide specifics, which may cause investor concern. Overall, the sentiment is balanced by positive cost management and restructuring efforts but offset by sales declines and vague guidance. This results in a neutral outlook for the stock price over the next two weeks.
SNBR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
